Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes

Part of paid clinical trials in Dallas, Texas.

Sponsor: University of Texas Southwestern Medical Center
Study ID: NCT04540536
Status: Completed

Conditions

Diabetes Mellitus, Type 1
Noncompliance, Patient

Eligibility Criteria

Sex: ALL
Age: 13 Years - 18 Years
Healthy Volunteers: Not accepted

Interventions

Continuous Glucose Monitoring — OTHER
Participants will be provided with a Dexcom G6 continuous glucose monitor for the duration of the study.
Secure texting — OTHER
A secure platform (TigerConnect) will be used for three-way communication between parents, participants, and clinical personnel

Study Details

Adolescents with Type 1 Diabetes (age 13-18 years, T1D duration \>6 months managed on insulin) and poor glycemic control will wear a blinded CGM to obtain baseline data. After assuring adherence to CGM wear, participants will receive a non-blinded CGM and will share their blood glucose levels with the study team. Clinical personnel will remotely monitor patients in real-time for 3 months and communicate regularly over secure text messaging with participants and their parents. Following active remote monitoring, the participants will wear a non-blinded CGM for 3 months. Primary outcome assessment will be the change in HbA1c after 3 months of real-time remote continuous glucose monitoring.